Oragenics Inc
OGEN· NYSE
OGENOragenics Inc
Filed Aug 10, 2012 · 10-Q · 41 days after period end · 0001193125-12-348771
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $256.41K | $347.57K | $304.70K |
| Net Income | -$6.93M | -$2.37M | -$2.01M |
| EPS Diluted | -$0.52 | -$0.42 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 10, 2012 · 41 d after period end
